SPPI Spectrum Pharmaceuticals Inc

Spectrum Pharmaceuticals Inc is a biotechnology company in the United States. It develops drugs to cure serious diseases such as chemotherapy-induced neutropenia in patients with breast cancer.

$2.97  +0.03 (0.85%)
As of 04/13/2021 15:59:48 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/05/2001
Outstanding shares:  153,728,336
Average volume:  2,523,590
Market cap:   $451,961,308
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    84763A108
ISIN:        US84763A1088
Sedol:      2982924
Valuation   (See tab for details)
PE ratio:   -9.33
PB ratio:   3.10
PS ratio:   -451,961.31
Return on equity:   -90.22%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy